Influence of HRT on cardiovascular diseases - review of literature
Journal Title: Przegląd Menopauzalny - Year 2006, Vol 24, Issue 2
Abstract
In the article authors discuss the influence of HRT (hormonal replacement therapy) and ERT (estrogen replacement therapy) on frequency of cardiovascular events. There are controversies between conclusions from studies: observational and prospective, clinical (ERA, HERS, WHI). It may be caused by differences in women’s populations which were included into analysis in these studies. It is probable that important factors which have influence on effect of used therapy are: time from menopause and progression of atherosclerosis. There may be also big clinical differences between doses, routes of administration and types of hormones. Results of laboratory tests suggest that transdermal therapy, in comparison with oral route, may give better results concerning cardiovascular events. These facts need to be determined in prospective, randomized clinical studies. Because the situation concerning influence of HRT and ERT on cardiovascular diseases is not clear, during individual therapeutic decisions potential benefits and risks must be taken into account. This includes moment of beginning of the therapy, route of administration, doses and types of hormones. Early beginning of the therapy may have positive influence on lower incidence of cardiovascular events. Late first administration of hormones may lead to higher risk of complications. Although we do not have evident clinical proof which show higher safety of transdermal forms, these forms should be seen as first-choice in all women with indications to HRT and ERT.
Authors and Affiliations
Grzegorz Surkont, Ryszard Wlazłowski, Edyta Wlaźlak, Jacek Suzin
Keywords
Related Articles
- EP ID EP128778
- DOI -
- Views 50
- Downloads 0
Influence of HRT on cardiovascular diseases - review of literature
In the article authors discuss the influence of HRT (hormonal replacement therapy) and ERT (estrogen replacement therapy) on frequency of cardiovascular events. There are controversies between conclusions from studies: o...
Miejscowe stosowanie estrogenów
W pracy przedstawiono zaktualizowane dane dotyczące miejscowego stosowania estrogenów. Omówiono podstawy molekularne oddziaływań estrogenów na poziomie receptorowym i mechanizmy pozareceptorowe, ze szczególnym uwzględn...
Prognostic significance of sVEGFR-1 in indentification of resistance to cisplatin and paclitaxel chemotherapy in ovarian cancer patients
Objectives: Most of the patients (>80%) with ovarian cancer require primary debulking surgery and adjuvant chemotherapy as a standard treatment. Chemotherapy including paclitaxel and cisplatin/carboplatin is mainly used...
Rola inhibitora aktywatora plazminogenu 1 (PAI-1) po menopauzie – wpływ terapii hormonalnej tego okresu
PAI-1 to ważny inhibitor w układzie fibrynolizy. W artykule przedstawiono związek tej glikoproteiny z chorobami układu krążenia, otyłością i nowotworami w grupie kobiet pomenopauzalnych. Podwyższony poziom PAI-1 po men...
Stres, objawy i przekonania dotyczące menopauzy a obniżony nastrój u kobiet w wieku 45–55 lat. Próba weryfikacji zmodyfikowanego psychospołecznego modelu depresji w okresie okołomenopauzalnym
Cel pracy: W artykule przedstawiono wyniki badań nad uwarunkowaniami obniżonego nastroju u kobiet w wieku okołomenopauzalnym. Podstawą teoretyczną badań była zmodyfikowana wersja psychospołecznego modelu depresji menopa...